|
AU2002333114B2
(en)
|
2001-11-30 |
2008-09-04 |
Qlt Inc. |
Hydrazonopyrazole derivatives and their use as therapeutics
|
|
US6770597B2
(en)
*
|
2002-07-17 |
2004-08-03 |
Ishihara Sangyo Kaisha, Ltd. |
Benzohydrazide derivatives as herbicides and desiccant compositions containing them
|
|
US7847101B2
(en)
|
2002-07-24 |
2010-12-07 |
Valocor Therapeutics, Inc. |
Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
|
|
DE60304718T2
(de)
|
2002-08-06 |
2007-04-26 |
Astrazeneca Ab |
Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
|
|
WO2004014886A1
(en)
*
|
2002-08-07 |
2004-02-19 |
University Of Mississippi |
Antigiardial agents and use thereof
|
|
GB0228417D0
(en)
|
2002-12-05 |
2003-01-08 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
|
GB0229618D0
(en)
|
2002-12-19 |
2003-01-22 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
|
SI1611112T1
(sl)
*
|
2003-02-11 |
2012-12-31 |
Vernalis (R&D) Limited |
Izoksazolne spojine kot inhibitorji vroäśinskih ĺ ok proteinov
|
|
US7589116B2
(en)
|
2003-04-03 |
2009-09-15 |
Merck & Co. Inc. |
Biaryl substituted pyrazoles as sodium channel blockers
|
|
GB0309637D0
(en)
|
2003-04-28 |
2003-06-04 |
Cancer Rec Tech Ltd |
Pyrazole compounds
|
|
GB0313915D0
(en)
*
|
2003-06-16 |
2003-07-23 |
Smithkline Beecham Corp |
Compounds
|
|
JPWO2005063222A1
(ja)
|
2003-12-26 |
2007-07-19 |
協和醗酵工業株式会社 |
Ｈｓｐ９０ファミリー蛋白質阻害剤
|
|
MXPA06007820A
(es)
*
|
2004-01-09 |
2006-09-01 |
Novartis Ag |
Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina como inhibidores de igf-ir.
|
|
GB0402518D0
(en)
|
2004-02-05 |
2004-03-10 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1604970A1
(en)
*
|
2004-05-19 |
2005-12-14 |
Cellzome Ag |
2-(Biphenyl-3-yl)-carboxylic acids of gamma-secretase-modulating activity
|
|
WO2005110963A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Cellzome Ag |
(biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
|
|
DE102004039280A1
(de)
*
|
2004-08-13 |
2006-02-23 |
Merck Patent Gmbh |
1,5-Diphenyl-pyrazole
|
|
JP4820758B2
(ja)
|
2004-09-22 |
2011-11-24 |
日本化薬株式会社 |
新規ブロック共重合体、ミセル調製物及びそれを有効成分とする抗癌剤
|
|
DE102004049078A1
(de)
*
|
2004-10-08 |
2006-04-13 |
Merck Patent Gmbh |
Phenylpyrazole
|
|
EP1817295B1
(en)
|
2004-11-18 |
2012-11-07 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
|
TW200639163A
(en)
*
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
|
DE102005007304A1
(de)
|
2005-02-17 |
2006-08-24 |
Merck Patent Gmbh |
Triazolderivate
|
|
US20090042883A1
(en)
*
|
2005-02-21 |
2009-02-12 |
Kyowa Hakkokogyo Co. |
Antitumor agent
|
|
DE102005009440A1
(de)
|
2005-03-02 |
2006-09-07 |
Merck Patent Gmbh |
Thienopyridinderivate
|
|
CN101160291B
(zh)
*
|
2005-03-09 |
2012-09-05 |
日本化药株式会社 |
作为hsp90抑制剂的三唑衍生物
|
|
JP5154406B2
(ja)
|
2005-04-13 |
2013-02-27 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
WO2006122546A1
(de)
*
|
2005-05-18 |
2006-11-23 |
Forschungsverbund Berlin E.V. |
Nicht-peptidische inhibitoren der akap-pka-wechselwirkung
|
|
FR2885904B1
(fr)
*
|
2005-05-19 |
2007-07-06 |
Aventis Pharma Sa |
Nouveaux derives du fluorene, compositions les contenant et utilisation
|
|
US7473784B2
(en)
*
|
2005-08-01 |
2009-01-06 |
Bristol-Myers Squibb Company |
Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
|
|
US7608635B2
(en)
|
2005-08-12 |
2009-10-27 |
Synta Pharmaceuticals Corp. |
Pyrazole compounds that modulate HSP90 activity
|
|
JP5118039B2
(ja)
|
2005-08-18 |
2013-01-16 |
シンタ ファーマシューティカルズ コーポレーション |
Ｈｓｐ９０活性を調節するトリアゾール化合物
|
|
NL2000351C2
(nl)
|
2005-12-22 |
2007-09-11 |
Pfizer Prod Inc |
Estrogeen-modulatoren.
|
|
EP2012791A4
(en)
*
|
2006-02-07 |
2010-09-22 |
Conforma Therapeutics Corp |
7,9-DIHYDRO-PURIN-8-ONE AND RELATED ANALOGUES AS INHIBITORS OF HSP90
|
|
US7754725B2
(en)
|
2006-03-01 |
2010-07-13 |
Astex Therapeutics Ltd. |
Dihydroxyphenyl isoindolymethanones
|
|
WO2007105058A2
(en)
*
|
2006-03-16 |
2007-09-20 |
Pfizer Products Inc. |
Pyrazole compounds
|
|
US8323669B2
(en)
|
2006-03-28 |
2012-12-04 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of taxane
|
|
RU2447095C2
(ru)
|
2006-05-18 |
2012-04-10 |
Ниппон Каяку Кабусики Кайся |
Высокомолекулярный конъюгат подофиллотоксинов
|
|
DE102006023336A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Merck Patent Gmbh |
1,5-Diphenyl-pyrazole II
|
|
US8063083B2
(en)
*
|
2006-05-25 |
2011-11-22 |
Synta Pharmaceuticals Corp. |
Method for treating non-Hodgkin's lymphoma
|
|
AU2007267843B2
(en)
*
|
2006-05-25 |
2011-10-13 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
|
SI2035396T1
(sl)
|
2006-05-25 |
2014-08-29 |
Synta Pharmaceuticals Corp. |
Triazolne spojine, ki modulirajo aktivnost HSP90
|
|
AR061185A1
(es)
|
2006-05-26 |
2008-08-13 |
Chugai Pharmaceutical Co Ltd |
Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas.
|
|
JP5548364B2
(ja)
*
|
2006-10-03 |
2014-07-16 |
日本化薬株式会社 |
レゾルシノール誘導体の高分子結合体
|
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
JP5410285B2
(ja)
|
2006-10-12 |
2014-02-05 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
EP2073807A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
JP5518478B2
(ja)
|
2006-10-12 |
2014-06-11 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
EP2073802A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
US8334364B2
(en)
|
2006-11-06 |
2012-12-18 |
Nipon Kayaku Kabushiki Kaisha |
High-molecular weight derivative of nucleic acid antimetabolite
|
|
JP5548365B2
(ja)
|
2006-11-08 |
2014-07-16 |
日本化薬株式会社 |
核酸系代謝拮抗剤の高分子誘導体
|
|
DE102007002715A1
(de)
|
2007-01-18 |
2008-07-24 |
Merck Patent Gmbh |
Triazolderivat
|
|
MX2009008756A
(es)
|
2007-03-01 |
2009-08-27 |
Chugai Pharmaceutical Co Ltd |
Compuesto macrociclico.
|
|
JPWO2008108386A1
(ja)
|
2007-03-05 |
2010-06-17 |
協和発酵キリン株式会社 |
医薬組成物
|
|
WO2008112199A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Synta Pharmaceuticals Corp. |
Method for inhibiting topoisomerase ii
|
|
WO2009016460A2
(en)
*
|
2007-08-01 |
2009-02-05 |
Pfizer Inc. |
Pyrazole compounds and their use as raf inhibitors
|
|
WO2009026658A1
(en)
*
|
2007-08-29 |
2009-03-05 |
The University Of Sydney |
Ppar agonists
|
|
JP2011501731A
(ja)
*
|
2007-09-10 |
2011-01-13 |
ユニバーシティ オブ マサチューセッツ |
ミトコンドリア標的化抗腫瘍剤
|
|
JP5349318B2
(ja)
|
2007-09-28 |
2013-11-20 |
日本化薬株式会社 |
ステロイド類の高分子結合体
|
|
CN101977631A
(zh)
|
2008-03-18 |
2011-02-16 |
日本化药株式会社 |
生理活性物质的高分子量偶联物
|
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
JP5366940B2
(ja)
|
2008-05-08 |
2013-12-11 |
日本化薬株式会社 |
葉酸若しくは葉酸誘導体の高分子結合体
|
|
WO2010001989A1
(ja)
*
|
2008-07-03 |
2010-01-07 |
協和発酵キリン株式会社 |
癌幹細胞及び／または癌前駆細胞の減少剤並びに癌の再発及び／または転移の予防剤
|
|
PT2324008E
(pt)
|
2008-07-24 |
2012-06-25 |
Nerviano Medical Sciences Srl |
3,4-diarilpirazoles como inibidores da proteína quinase
|
|
EP2151434A1
(en)
|
2008-08-05 |
2010-02-10 |
Institut Pasteur |
Alkoxypyrazoles and the process for their preparation
|
|
EP2151433A1
(en)
|
2008-08-05 |
2010-02-10 |
Institut Pasteur |
Alkoxypyrazoles and the process for their preparation
|
|
BRPI1008949B1
(pt)
*
|
2009-03-11 |
2018-07-10 |
Bayer Intellectual Property Gmbh |
Cetoenóis haloalquilmetilenóxi-fenil-substituídos e seu uso, composição, seu uso e seu método de produção, métodos para combate de pestes animais e/ou crescimento de plantas indesejadas
|
|
WO2010121963A1
(en)
|
2009-04-21 |
2010-10-28 |
Nerviano Medical Sciences S.R.L. |
Resorcinol derivatives as hsp90 inhibitors
|
|
JP5544357B2
(ja)
|
2009-05-15 |
2014-07-09 |
日本化薬株式会社 |
水酸基を有する生理活性物質の高分子結合体
|
|
NZ713361A
(en)
*
|
2009-08-17 |
2017-06-30 |
Memorial Sloan Kettering Cancer Center |
Heat shock protein binding compounds, compositions, and methods for making and using same
|
|
AR077975A1
(es)
|
2009-08-28 |
2011-10-05 |
Irm Llc |
Derivados de pirazol pirimidina y composiciones como inhibidores de cinasa de proteina
|
|
WO2011040421A1
(ja)
|
2009-09-29 |
2011-04-07 |
武田薬品工業株式会社 |
スクリーニング方法
|
|
TW201124406A
(en)
*
|
2009-10-07 |
2011-07-16 |
Karobio Ab |
Novel estrogen receptor ligands
|
|
CN104958294A
(zh)
*
|
2010-01-27 |
2015-10-07 |
内尔维安诺医学科学有限公司 |
作为蛋白激酶抑制剂的3,4-二芳基吡唑的亚磺酰氨基衍生物
|
|
JP2013519727A
(ja)
*
|
2010-02-17 |
2013-05-30 |
イルドン ファーム シーオー．，エルティーディー． |
新規の５員複素環誘導体及びその製造方法
|
|
EP2560640A1
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
EP2601185B1
(en)
|
2010-08-03 |
2015-10-07 |
Nerviano Medical Sciences S.r.l. |
Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
|
|
KR20140024833A
(ko)
|
2010-11-17 |
2014-03-03 |
니폰 가야꾸 가부시끼가이샤 |
신규한 시티딘계 대사길항제의 고분자 유도체
|
|
GB201113538D0
(en)
|
2011-08-04 |
2011-09-21 |
Karobio Ab |
Novel estrogen receptor ligands
|
|
CN103874722B
(zh)
|
2011-09-11 |
2016-06-29 |
日本化药株式会社 |
嵌段共聚物的制造方法
|
|
CA2853799A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
|
JP2014534228A
(ja)
|
2011-11-02 |
2014-12-18 |
シンタ ファーマシューティカルズ コーポレーション |
白金含有剤とｈｓｐ９０阻害剤の組合せ療法
|
|
RU2622015C2
(ru)
|
2011-11-11 |
2017-06-08 |
Новартис Аг |
Способ лечения пролиферативного заболевания
|
|
US9402831B2
(en)
|
2011-11-14 |
2016-08-02 |
Synta Pharmaceutical Corp. |
Combination therapy of HSP90 inhibitors with BRAF inhibitors
|
|
SI2782557T1
(sl)
|
2011-11-23 |
2019-02-28 |
Array Biopharma, Inc., |
Farmacevtske formulacije
|
|
CN103183640B
(zh)
*
|
2011-12-30 |
2016-04-27 |
沈阳药科大学 |
二芳基吡唑类化合物及其制备方法与用途
|
|
US20140079636A1
(en)
*
|
2012-04-16 |
2014-03-20 |
Dinesh U. Chimmanamada |
Targeted therapeutics
|
|
DE102013012685A1
(de)
*
|
2013-07-31 |
2015-02-05 |
Johann-Wolfgang-Goethe Universität Frankfurt am Main |
Arylierte Pyrazolderivate und deren Verwendung als Fluoreszenzfarbstoffe
|
|
CN104974091B
(zh)
*
|
2014-04-10 |
2018-01-02 |
沈阳药科大学 |
3‑甲基‑1,5‑二芳基吡唑类化合物及其制备方法和用途
|
|
JP6607870B2
(ja)
|
2014-05-13 |
2019-11-20 |
メモリアル スローン ケタリング キャンサー センター |
Ｈｓｐ７０モジュレーターならびにその作製および使用方法
|
|
FR3022244B1
(fr)
*
|
2014-06-17 |
2016-07-01 |
Centre Nat De La Rech Scient (Cnrs) |
Utilisation d'un nouveau compose 3-aryl-4-catechol-pyrrole-n-propanol et ses derives pour le traitement du cancer et des pathologies associees a une angiogenese excessive
|
|
EP3248968A4
(en)
*
|
2015-01-22 |
2018-11-07 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Resorcinol derivative as hsp90 inhibitor
|
|
GB201706806D0
(en)
|
2017-04-28 |
2017-06-14 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
CA3067572A1
(en)
|
2017-06-20 |
2018-12-27 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
KR20200016874A
(ko)
|
2017-06-20 |
2020-02-17 |
마드리갈 파마슈티칼스 인코포레이티드 |
표적화 치료제를 포함하는 병용 요법
|
|
WO2019236765A1
(en)
*
|
2018-06-05 |
2019-12-12 |
Flagship Pioneering Innovations V, Inc. |
Acylated catechin polyphenols and methods of their use for the treatment of cancer
|
|
CN109134204B
(zh)
*
|
2018-11-16 |
2022-03-08 |
棓诺(苏州)新材料有限公司 |
中间体2-溴-4-氟-5-氯苯酚的合成法
|
|
CN110283080A
(zh)
*
|
2019-07-05 |
2019-09-27 |
山西大学 |
一种含氟的二苯甲酮衍生物及其制备方法和应用
|
|
EP3827825A1
(en)
*
|
2019-11-26 |
2021-06-02 |
Wageningen Universiteit |
Use of 3, 4-diarylpyrazoles as antibacterial agents
|
|
US20230348454A1
(en)
*
|
2020-09-14 |
2023-11-02 |
Genzyme Corporation |
Compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell disease
|
|
WO2022232259A1
(en)
*
|
2021-04-28 |
2022-11-03 |
Cornell University |
Soluble adenylyl cyclase (sac) inhibitors and uses thereof
|
|
WO2023004280A1
(en)
*
|
2021-07-19 |
2023-01-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Selective pyrazole lrrk2 inhibitors and methods for use thereof
|
|
CN120623147B
(zh)
*
|
2025-08-01 |
2025-12-16 |
广东省科学院动物研究所 |
吡唑喹啉醚类化合物及其在制备神经保护药物中的应用
|